Healthcare
Apax backs Chinese cosmetic surgery marketplace
A technology-focused fund managed by Apax Partners has led a $60 million Series D round of funding for SoYoung, a Chinese online marketplace specializing in cosmetic surgery.
INCJ joins $33m Series C for Japan's Megakaryon
Innovation Network Corporation of Japan (INCJ) has joined a JPY3.7 billion ($33 million) Series C funding round for Megakaryon, a domestic medical research company.
OrbiMed re-ups in India's Vivimed Labs
OrbiMed has invested a further $7.5 million in the active pharmaceutical ingredient (API) unit of India-listed drug maker Vivimed Labs.
J-Star exits Japan's Aisei Pharmacy to management team
J-Star has agreed to exit Japanese drugstore chain Aisei Pharmacy to company management less than two years after completing a JPY11.4 billion ($101 million) privatization.
AVCJ Awards 2017: VC Professionals of the Year: JP Gan & Nisa Leung
J.P. Gan and Nisa Leung, managing partners at Qiming Venture Partners, discuss the latest trends they are seeing in China’s consumer internet and healthcare spaces
Carlyle growth fund buys India BPO player
The Carlyle Group has acquired Indian healthcare business process outsourcing (BPO) provider Visionary RCM Infotech through its latest Asia growth fund, Carlyle Asia Growth Partners V (CAGP V).
Temasek leads $80m round for Singapore biopharma player
Singapore’s Temasek Holdings has led an $80 million funding round for domestic biopharmaceutical company Tessa Therapeutics with support from a number of venture and growth capital investors.
AVCJ Awards: Fundraising of the Year - Venture Capital: Lilly Asia Ventures
Lilly Asia Ventures’ rapid-fire $450 million fundraise reflects increasing LP interest in the opportunities offered by the Chinese healthcare sector
Hony-backed healthcare platform acquires TCM hospital
Hospital Corporation of China (HCC), a buyout platform established by Hony Capital, has acquired a 70% stake in Jiande Hexu Enterprise Management, owner of a traditional Chinese medicine (TCM) hospital and other healthcare businesses, for RMB483 million...
Profile: KPCB China's James Huang
James Huang, a managing partner at KPCB China, has launched his own healthcare-focused investment firm to put his incubation and operational skills to work with a new generation of Chinese start-ups
ICICI Venture set to part-exit India's KIMS via IPO
India’s ICICI Venture Funds Management will exit part of its stake in Krishna Institute of Medical Sciences (KIMS) in a planned domestic IPO.
NSI hits first close on Fund II, backs Singapore healthcare start-up
NSI Ventures has reached a first close of approximately $60 million on its second Southeast Asia venture capital fund and also participated in a $5 million Series A round for Singapore-based digital healthcare company Biofourmis.
Yunfeng joins Chinese consortium in Italy healthcare acquisition
Yunfeng Capital has teamed up with a group of Chinese strategic and financial investors to acquire 100% of Esaote, an Italy-headquartered manufacturer of medical diagnostic systems. The deal facilitates an exit for Ares Life Sciences among other investors.
China’s 6 Dimensions raises $844m for debut healthcare fund
China’s 6 Dimensions Capital, which was formed through the merger of WuXi Healthcare Ventures and Frontline BioVentures, has raised approximately $844 million for its debut healthcare fund.
MicuRx Pharma gets $15m to support China drug trials
MicuRx Pharmaceuticals, a Sino-US bio-pharmaceutical company, has received RMB100 million ($15.1 million) in funding in a round led by existing investors Delian Capital and BVCF.
SBCVC leads $30m round for China healthcare AI firm
SBCVC has led a RMB200 million ($30 million) Series B round for 12 Sigma, a China-based biotechnology company that applies artificial intelligence (AI) technology to medical image diagnoses.
Ping An Capital invests $121m in Singapore's Fullerton Healthcare
Ping An Capital, an investment unit of China’s Ping An Insurance, has invested more than RMB800 million ($121 million) in Fullerton Healthcare Corporation, which provides healthcare services to more than 25,000 corporations in Asia.
SDIC, AstraZeneca agree China pharma JV
SDIC Fund Management, a GP under China’s State Development & Investment Corporation (SDIC), and AstraZeneca have formed a China-based joint venture that will develop and commercialize new medicines.
Deal focus: Traphaco wins with the direct approach
Mekong Capital's 6.3x return on its investment in Vietnam-based pharmaceuticals player Traphaco involved turning the company's distribution model on its head, as well as supporting expansion and improving governance
China Renaissance adds strategies, targets $10b in AUM by 2020
China Renaissance has added dedicated healthcare and mezzanine debt strategies to its existing growth-stage private equity offering as part of efforts to more than treble its assets under management (AUM) over the next three years.
China cancer treatment developer receives $101m
China Venture Capital Fund, a VC vehicle backed by the Chinese government, and ChinaEquity Group have jointly led a RMB670 million ($101 million) round for 3D Medicines, which focuses on personalized diagnostics and treatment for cancer.
Everstone acquires Malaysia's Chemopharm
The Everstone Group has acquired Chemopharm, a provider of medical equipment based in Malaysia.
Sabre, CDC lead $26m Series C for India's Portea
Sabre Partners and CDC Group have co-led a $26 million Series C round for Indian home healthcare business Portea Medical.
Mekong exits Vietnam's Traphaco for $64.5m
Vietnam’s Mekong Capital has exited its 25% stake in domestic pharmaceuticals company Traphaco for about $64.5 million. It represents a gross return multiple of 6.3x for the investment.